Zeiss axio imager M2
Ended Awarded
- Contract number
- 75N91022F00150
- Awardee
-
Carl Zeiss Microscopy, LLC UEI H41JAKKNEXY1
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $97,555
Award facts
- Contract value 100% obligated
- $97,554.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 333314 Optical Instrument and Lens Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- White Plains, NY 10601, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute (NCI) awarded a $97,554.52 firm fixed price contract to Carl Zeiss Microscopy, LLC on May 19, 2022, for a ZEISS AXIO IMAGER M2 microscopy system. This award was issued as a call against an existing Blanket Purchase Agreement (BPA), with an ultimate completion date of August 31, 2022. The contract carries no small business set-aside designation and will be performed at the contractor's facility in White Plains, New York. Carl Zeiss Microscopy, a foreign-owned manufacturer of advanced optical and microscopy equipment, was selected based on its technical capabilities and competitive positioning in the federal marketplace.
This procurement supports NCI's research infrastructure and oncology research initiatives by providing advanced microscopy capabilities essential for cancer research and diagnostics. The AXIO IMAGER M2 is a versatile light microscopy platform commonly used in biomedical research applications. Carl Zeiss Microscopy maintains significant federal contracting relationships, including a $62.1 billion General Services Administration Multiple Award Schedule contract and the $10 million BPA under which this award was issued, enabling federal agencies to efficiently procure specialized microscopy solutions and associated technical support services across the National Institutes of Health enterprise.
Quick answers
Who was awarded contract 75N91022F00150?
75N91022F00150 was awarded to Carl Zeiss Microscopy, LLC by National Cancer Institute (National Institutes of Health) on May 19, 2022.
How much is contract 75N91022F00150 worth?
The government has obligated $97,555 on 75N91022F00150.
Is contract 75N91022F00150 an order under another contract?
Yes. 75N91022F00150 is a BPA call under 75N98021A00029, a blanket purchase agreement.
Was contract 75N91022F00150 competed?
The extent of competition for 75N91022F00150 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award